Bank of America
CALT

Bank of America’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Bank of America’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-656
Closed -$25.6K – 8480
2024
Q2 		$25.6K Sell
656
-386
-37% -$10.6K ﹤0.01% 6680
2024
Q1 		$21.9K Buy
1,042
+729
+233% +$16.2K ﹤0.01% 6735
2023
Q4 		$8.06K Sell
313
-443
-59% -$8.29K ﹤0.01% 6932
2023
Q3 		$13.8K Buy
756
+441
+140% +$7.63K ﹤0.01% 6789
2023
Q2 		$4.99K Buy
315
+19
+6% +$401 ﹤0.01% 6993
2023
Q1 		$7.09K Buy
296
+88
+42% +$1.76K ﹤0.01% 6996
2022
Q4 		$3.54K Buy
+208
New +$3.35K ﹤0.01% 7126
2022
Q3 		– Sell
-213
Closed -$4K – 8289
2022
Q2 		$4K Sell
213
-589
-73% -$10.3K ﹤0.01% 7668
2022
Q1 		$16K Sell
802
-498
-38% -$9.99K ﹤0.01% 7613
2021
Q4 		$32K Buy
1,300
+1,107
+574% +$22.2K ﹤0.01% 7384
2021
Q3 		$4K Buy
+193
New +$5.29K ﹤0.01% 7787

Other funds holding CALT

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return

Bank of America's CALT Position: Q3 2024 in Review

Bank of America sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2024, closing a stake of 656 shares — an estimated $25.6K sold.

Bank of America first reported a position in CALT in Q3 2021 and held it in 11 quarters. The position peaked at $32K in Q4 2021. 5 funds tracked by Wall St. Rank hold CALT as of Q3 2024.

  • Bank of America reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Bank of America sold 656 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2024, an estimated $25.6K.
  • Bank of America first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q3 2021 and held it in 11 quarters.
  • Bank of America's Calliditas Therapeutics AB American Depositary Shares position peaked at $32K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2024.

Based on Bank of America's 13F filing for Q3 2024, filed 14 Nov 2024.